The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
In the last four decades, several classes of diuretics have been the first line option for the therapy of widespread hypertension. However, all the classes of diuretics cause alteration of potassium homeostasis. The primary objective of this study is to assess the safety and tolerability of SHR0532 tablets in healthy subjects. In addition, this study will provide information on Pharmacokinetics and Pharmacodynamics of SHR0532 tablets in healthy subjects.
Epistemonikos ID: c8a4644e485e51de877640aea435e287cdd7545d
First added on: May 21, 2024